This page will populate with election results as they are released. Results reflect in-person ballots cast during early voting and on Election Day, as well as mail ballots received and counted. State ...
Good day, and welcome to the Tango Therapeutics conference call. [Operator Instructions] Please note, this call is being recorded. I'd now like to turn the call over to Liz Hickin, Vice President, ...
A shift in the way people think about and treat pancreatic cancer could be on the horizon based on positive results from the pivotal randomized phase 3 RASolute 302 trial comparing daraxonrasib to ...
Gov. Gavin Newsom cannot run again because of term limits. The leading Democrats trying to succeed him are Xavier Becerra, a former California attorney general; and Tom Steyer, a former hedge fund ...
- The trial achieved its primary goal of selecting the efficacious and safe dose of onvansertib + standard-of-care (SoC) regimen for the registrational program - - 30 mg onvansertib + ...
Primary contests will be held in six states on Tuesday. We’ll be paying close attention to California, where dozens of candidates are vying to replace Gov. Gavin Newsom in an open primary. Here’s what ...
At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...
At the ASCO annual meeting, Dana-Farber’s Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing a substantial prolongation of survival for patients with previously ...
Carter County leaders passed a new budget Monday.There's no tax increase, but some programs are now without county funding.The county's property tax rate will b Washington County, Va., judge ...
BATON ROUGE, La. (WAFB) - Louisiana voters are headed to June runoffs in both the Republican and Democratic primaries for the U.S. Senate after Saturday’s statewide election under the state’s new ...
The targeted RAS inhibitor daraxonrasib was found to be safe and showed signs of efficacy in patients with previously treated RAS-mutant metastatic pancreatic cancer, according to a Phase I/II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results